Wednesday, March 10, 2010
"The source for European pharmaceutical biotechnology news..."
Sponsors
Platinum Sponsors
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Marie Shields
Editor NGP Europe
Editor NGP Europe
Tough competition
The battle between generics and branded products has been going on for a long time: the claims and counter claims over Aspirin, for example, have been in process since the early 20th century.05 Aug 2009
Focus Areas
Cover Stories
Producing the goods
Looking at the new manufacturing principles squeezing more value out of pharma.
India calling
India is often thought of as the hub for industrial outsourcing. But is it right for pharma? Rob Plastow has been looking the impact on...
Roundtables
-
The Executive Roundtable
Kevin Hrusovsky of Caliper Life Sciences, Nick Hughes from PA Consulting Group, David Weber of Stratagene, and Whatman's Dr Jens Beator offer their views on pharma's...Read more
Vendor Perspectives
-
iPath™ - Online functional genomics and ...
Human biological pathways at your fingertips. By InvitrogenRead more -
The growing importance of turnkey supply...
The pharmaceutical industry is very fragmented, with numerous drug dosage forms for solid, liquid and semi-liquid applications. By Bosch Sigpack SystemsRead more
Industry Analysts
-
Banking on it
Despite growing interest, biobank use still faces a number of hurdles – from IT to governance. Will we ever fully realise the full potential of these hugely important...Read more -
Higher learning
Steven Rauschkolb of the Society of Pharmaceutical and Biotech Trainers explains how the training sector has evolved to ensure you can get the best out of your staff.Read more -
The PAT initiative: a real-time insight
Quality control is a major issue in pharmaceutical manufacturing. With the Process Analytical Technology initiative, the FDA is striving for greater efficiency and cost...Read more -
Advances in bioreactor agitation
In the critical part of scaling up a cell culture system it is often found that insufficient attention is given in bid specifications to the bioreactor agitator. By Neil...Read more
Executive Interviews
Bioinformatics
Bioinformatics is playing an increasingly important role in drug development and our understanding of complex genetic and molecular information. Simon Smith, Head of Bioinformatics, J&J talks to NGP about growth and potential breakthroughs.
Read more
NGP Europe Summit: Drug Discovery
1st - 3rd September 2010
The Next Generation Drug Discovery Summit Europe is designed to bridge the growing technological gap between drug discovery and drug development.
Source: www.ngpharma.eu.com© 2010 GDS Publishing Ltd. All rights reserved.